Yaniv I - Search Results

1

Excellent prognosis in a subset of patients with Ewing sarcoma identified at diagnosis by CD56 using flow cytometry.

Ash S, Luria D, Cohen IJ, Goshen Y, Toledano H, Issakov J, Yaniv I, Avigad S. Ash S, et al. Among authors: yaniv i. Clin Cancer Res. 2011 May 1;17(9):2900-7. doi: 10.1158/1078-0432.CCR-10-3069. Epub 2011 Apr 5. Clin Cancer Res. 2011. PMID: 21467162

2

The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors.

Avigad S, Cohen IJ, Zilberstein J, Liberzon E, Goshen Y, Ash S, Meller I, Kollender Y, Issakov J, Zaizov R, Yaniv I. Avigad S, et al. Among authors: yaniv i. Cancer. 2004 Mar 1;100(5):1053-8. doi: 10.1002/cncr.20059. Cancer. 2004. PMID: 14983502 Free article.

3

Telomere length is a prognostic factor in neuroblastoma.

Ohali A, Avigad S, Ash S, Goshen Y, Luria D, Feinmesser M, Zaizov R, Yaniv I. Ohali A, et al. Among authors: yaniv i. Cancer. 2006 Sep 15;107(6):1391-9. doi: 10.1002/cncr.22132. Cancer. 2006. PMID: 16917952 Free article.

4

Novel approaches for the management of patients with Ewing sarcoma.

Avigad S, Yaniv I. Avigad S, et al. Among authors: yaniv i. Future Oncol. 2006 Oct;2(5):659-65. doi: 10.2217/14796694.2.5.659. Future Oncol. 2006. PMID: 17026457 Review.

5

Short telomeres: a novel potential predictor of relapse in Ewing sarcoma.

Avigad S, Naumov I, Ohali A, Jeison M, Berco GH, Mardoukh J, Stark B, Ash S, Cohen IJ, Meller I, Kollender Y, Issakov J, Yaniv I. Avigad S, et al. Among authors: yaniv i. Clin Cancer Res. 2007 Oct 1;13(19):5777-83. doi: 10.1158/1078-0432.CCR-07-0308. Clin Cancer Res. 2007. PMID: 17908968

6

Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).

Stark B, Avigad S, Luria D, Manor S, Reshef-Ronen T, Avrahami G, Yaniv I. Stark B, et al. Among authors: yaniv i. Pediatr Blood Cancer. 2009 Jan;52(1):20-5. doi: 10.1002/pbc.21823. Pediatr Blood Cancer. 2009. PMID: 19006253

7

Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.

Avigad S, Shukla S, Naumov I, Cohen IJ, Ash S, Meller I, Kollender Y, Issakov J, Yaniv I. Avigad S, et al. Among authors: yaniv i. Pediatr Blood Cancer. 2009 Dec;53(6):1023-8. doi: 10.1002/pbc.22115. Pediatr Blood Cancer. 2009. PMID: 19637319

8

Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94.

Ash S, Yaniv I, Toledano H, Stein J, Kollender Y, Fenig E, Konen O, Bar-Sever Z, Issakov J, Avigad S, Cohen IJ. Ash S, et al. Among authors: yaniv i. J Pediatr Hematol Oncol. 2019 Mar;41(2):105-111. doi: 10.1097/MPH.0000000000001384. J Pediatr Hematol Oncol. 2019. PMID: 30570510 Clinical Trial.

9

The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth.

Hameiri-Grossman M, Porat-Klein A, Yaniv I, Ash S, Cohen IJ, Kodman Y, Haklai R, Elad-Sfadia G, Kloog Y, Chepurko E, Feinmesser M, Issakov J, Sher O, Luria D, Kollender Y, Weizman A, Avigad S. Hameiri-Grossman M, et al. Among authors: yaniv i. Oncotarget. 2015 Oct 20;6(32):33834-48. doi: 10.18632/oncotarget.5616. Oncotarget. 2015. PMID: 26393682 Free PMC article.

10

Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome.

Amir G, Issakov J, Meller I, Sucher E, Peyser A, Cohen IJ, Yaniv I, Ben Arush MW, Tavori U, Kollender Y, Ron N, Peylan-Ramu N. Amir G, et al. Among authors: yaniv i. Hum Pathol. 2002 Feb;33(2):170-4. doi: 10.1053/hupa.2002.31475. Hum Pathol. 2002. PMID: 11957141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters